For the Three Months
Ended December 31, |
For the Year
Ended December 31, | |||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||
Non-GAAP Net Loss: | ||||||||||||||||
Net loss(1) | $ | (10,553 | ) | $ | (25,814 | ) | $ | (67,465 | ) | $ | (79,043 | ) | ||||
Add (deduct): | ||||||||||||||||
Depreciation and amortization(2) | 2,799 | 2,103 | 10,738 | 7,819 | ||||||||||||
Stock-based compensation(3) | 5,896 | 5,124 | 22,118 | 19,172 | ||||||||||||
Amortization of lease intangible | 180 | 333 | 950 | 1,332 | ||||||||||||
Amortization of deferred costs on convertible notes | 464 | 468 | 1,860 | 1,718 | ||||||||||||
Loss on marketable securities | — | 196 | — | 1,855 | ||||||||||||
Acquisition and other (5) | 481 | 566 | 824 | (676 | ) | |||||||||||
Loss on sale of property and equipment | — | (24 | ) | 92 | 47 | |||||||||||
Charitable contribution of common stock | 333 | — | 1,029 | 2,272 | ||||||||||||
Lease abandonment and termination (4) | — | — | 8,778 | — | ||||||||||||
Impairment of assets | — | 380 | 397 | 824 | ||||||||||||
Restructuring charge (6) | — | 1,549 | 738 | 1,549 | ||||||||||||
Costs to exit the supplies business | — | — | 586 | — | ||||||||||||
Non-GAAP Net Loss | $ | (400 | ) | $ | (15,119 | ) | $ | (19,355 | ) | $ | (43,131 | ) | ||||
Weighted-average number of shares outstanding used to compute Non-GAAP Net Loss per share, basic and diluted, of Class A and Class B common stock | 48,096,142 | 47,457,139 | 47,914,039 | 47,158,247 | ||||||||||||
EPS, basic and diluted, of Class A and Class B common stock | $ | (0.22 | ) | $ | (0.54 | ) | $ | (1.41 | ) | $ | (1.68 | ) | ||||
Non-GAAP EPS, basic and diluted, of Class A and Class B common stock | $ | (0.01 | ) | $ | (0.32 | ) | $ | (0.40 | ) | $ | (0.91 | ) |
Xometry Reports Fourth Quarter and Full Year 2023 Results
| | More MCAD News |
|
RELATED NEWS